Celltrion Healthcare receives EC approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, Y

Celltrion Healthcare receives EC approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, Y admin Wed, 02/17/2021 - 16:50

source https://www.pharmatutor.org/content/february-2021/celltrion-healthcare-receives-ec-approval-for-the-first-high-concentration-low-volume-and-citrate-free-biosimilar-adalimumab-y